Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) [Phase 2, Phase 3]
Clinical trial update for the Stop Ig study, assessing whether antibiotic therapy or immunoglobulin use affects infection management and dec…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) [Phase 2, Phase 3]
A Monash University trial is testing antibiotic therapy or intravenous immunoglobulin dosing to prevent infections in hematologic cancer pat…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) [Phase 2, Phase 3]
A hematology platform trial (RATIONAL-PT) is evaluating the roles of antibiotic therapy or immunoglobulin for infections in patients with he…
-
CLINICAL_TRIALS other · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) [Phase 2, Phase 3]
Clinical trial update for Start Ig, a Phase 2/3 study investigating whether antibiotic therapy or intravenous immunoglobulin reduces infecti…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
The document announces a new clinical trial called HALO-SCT, assessing high-altitude observation in stem cell transplantation. It is current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy [Phase 2]
Phase 2 trial of ofatumumab for minimal residual disease and maintenance therapy in leukemia and lymphoma was terminated; results have been …
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation [Phase 2]
This Phase 2 trial update reports termination of a study evaluating eltrombopag to reverse poor graft function after allogeneic hematopoieti…
-
EMA approval · 2025-09-25EMA Authorised: Xaluprine (previously Mercaptopurine Nova Laboratories) (6-mercaptopurine monohydrate) — Lipomed GmbH
EMA authorised Xaluprine (6-mercaptopurine monohydrate) by Lipomed GmbH for leukemia/lymphoid indications.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients [NA]
A pilot lifestyle intervention trial is recruiting patients with myeloproliferative neoplasms and leukemia at Massachusetts General Hospital…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. [NA]
This clinical trial update outlines a study evaluating whether an early warning system affects prognosis for patients with hematological mal…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia [Phase 1]
A Phase 1 trial is investigating whether metformin can inhibit DNMT3A-mutant clonal hematopoiesis in acute leukemia; the study is not yet re…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients [NA]
An update on the feasibility of an adapted fencing-based sports program to counter physical deconditioning in adults with leukemia or lympho…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study [NA]
This clinical trial update reports the completion of the ASCENT pain management intervention study with results posted for a future pragmati…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients [Phase 1]
Phase 1 trial evaluating Itacitinib with high-dose posttransplantation cyclophosphamide in older patients. The study is currently ACTIVE_NOT…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]
Biotroy Therapeutics is conducting a Phase 1/2 study of BT02 for relapsed or refractory hematologic malignancies, with recruitment not yet s…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: HEME Home Transfusion Program [NA]
Clinical trial update indicates that the HEME Home Transfusion Program is currently recruiting for hematologic conditions including leukemia…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT [Phase 1]
A Phase 1 trial evaluating total body irradiation delivered with IMRT (VMAT or Tomotherapy) to prevent pulmonary toxicities in patients unde…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Early Palliative Care in Patient With Acute Leukaemia [NA]
An update indicates a clinical trial evaluating early palliative care for patients with relapsed acute leukemia has completed. Sponsor: Hosp…
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Expanded Access Program for Revumenib
The expanded access program for Revumenib has been terminated and is no longer available.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
This clinical trial update outlines an approach to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation by …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events dur…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Pilot of a Trial Enrollment Diversity Dashboard [NA]
This document describes a pilot project to develop a Trial Enrollment Diversity Dashboard for a leukemia study, sponsored by Dana-Farber Can…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 [NA]
This clinical trial update notes that the MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 study is curre…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
A clinical trial update evaluating serum histone succinylation as a prognostic biomarker in hematological malignancies, including leukemia a…